Infocom And KNIME GmbH Jointly Develop Modules for Drug Development Technology
This article was originally published in PharmAsia News
Tokyo-based Infocom Corp, a system developer for pharmaceutical research facilities, has signed a licensing agreement with the German firm KNIME GmbH for developing and marketing business computer processing modules based on KNIME, a work flow platform designed to assist drug development research. KNIME, developed by Konstanz University in Germany, is an open system platform which is customizable for different modules and systems. Additionally, Infocom's licensing agreements with Hungarian company ChemAxon and KNIME have allowed it to develop the cheminformatics program suite JChem Node Extension, expected to launch in February 2008. (Click here for more-Japanese language
You may also be interested in...
During a recent press briefing, health officials in China disclosed the country is poised to reach an annual production capacity of 610 million doses for coronavirus vaccines. But they said prices must be based on manufacturing costs and not driven by supply and demand.
Biocon Biologics upbeat on Lantus follow-on’s long revenue stream and prospects for interchangeability, while operational challenges resulted in some supply constraints during the fiscal second quarter.
Join us for a quick audio roundup of major developments in the international biopharma industry over the past week, as covered by Scrip's global team.